Insider transactions

Neil Gagnon

CIK 1070170 · last filed 2024-10-07

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$114.44M
Companies
13
Total Filings
270
Lifetime Open-Market Net
-$26.24M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

GFNSL price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
1370 AVENUE OF THE AMERICAS
26TH FLOOR
NEW YORK, NY 10019
Related Filers
RUDOLPH TECHNOLOGIES INC — 3 joint filings, latest 2016-11-04
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PSIX 10%+ Owner 531,306 $48.89 $25.98M $498.0K 37 2024-10-07
SecureWorks Corp (SCWX) Delisted 10%+ Owner 662,977 $8.51 $5.64M $5.85M 42 2024-06-05
Apollo Endosurgery, Inc. (APEN) Delisted 10%+ Owner 440,408 $10.00 $4.40M $660.6K 10 2021-10-18
General Finance CORP (GFNSZ) Delisted 10%+ Owner 667,240 $28.46 $18.99M -$14.58M 17 2021-04-21
General Finance CORP (GFNSL) Delisted 10%+ Owner 16,236 — — -$18.18M 44 2019-01-31
CDNA 10%+ Owner 1,032,252 $70.75 $73.03M $3.10M 40 2018-11-02
AMRC 10%+ Owner 648,693 $20.39 $13.23M $367.3K 9 2016-12-13
General Finance CORP (GFNS.L) Delisted 10%+ Owner 1,218,742 — — $1.21M 12 2016-08-12
AMBR 10%+ Owner 1,304,364 $1.69 $2.20M $22.3K 1 2016-02-17
General Finance CORP (GFNC.P) Delisted 10%+ Owner 7,566,644 — — -$3.46M 34 2014-03-28
General Finance CORP (GFNC.Z) Delisted 10%+ Owner 7,903,952 — — -$1.45M 15 2013-06-18
NTS, INC. (VRS) Delisted 10%+ Owner 3,184,133 $26.99 $85.94M -$161.0K 8 2012-09-21
General Finance CORP (GFNCZ) Delisted 10%+ Owner 5,631,140 — — -$114.2K 1 2012-05-24

Recent Filings · Page 9 of 27

270 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-07-08 Apollo Endosurgery, Inc. (APEN) Delisted Other (J) +4,338 $0 EDGAR
2021-06-15 Apollo Endosurgery, Inc. (APEN) Delisted Mixed +138,239 $129 EDGAR
2021-04-21 General Finance CORP (GFNSZ) Delisted Sell (S) −640,918 -$12.17M EDGAR
2021-04-13 Apollo Endosurgery, Inc. (APEN) Delisted Buy (P) +303 $1.7K EDGAR
2021-02-24 Apollo Endosurgery, Inc. (APEN) Delisted Buy (P) +22,324 $104.9K EDGAR
2021-02-22 Apollo Endosurgery, Inc. (APEN) Delisted Buy (P) +2,027 $9.6K EDGAR
2021-02-08 Apollo Endosurgery, Inc. (APEN) Delisted Buy (P) +53,543 $259.8K EDGAR
2021-02-05 Apollo Endosurgery, Inc. (APEN) Delisted Buy (P) +38,117 $172.4K EDGAR
2021-02-03 Apollo Endosurgery, Inc. (APEN) Delisted Buy (P) +11,346 $50.0K EDGAR
2021-01-11 General Finance CORP (GFNSZ) Delisted Sell (S) −823 -$83.0K EDGAR
Showing 81–90 of 270
Page 9 of 27
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.